EMCDDA 25 Years of Monitoring
In 2020, the EMCDDA celebrates 25 years of monitoring the drug situation in Europe.
Search
EU4MD Bursaries for the 2020 NIDA International Forum
Professionals, academics and experts from European Neighbourhood Policy (ENP) countries will have the opportunity to participate in the 2020 National Institute on Drug Abuse International Forum, thanks to five bursaries being offered...
ASAP-Training Newsletter
The aim of the ASAP training project is to build effective drug prevention results across Europe, based on prevention systems analysis and widespread professional training.
The ASAP training project will work to identify the strengths and...
EU Drug Markets Report 2019
The EU Drug Markets Report 2019 is the third comprehensive overview of illicit drug markets in the European Union by the EMCDDA and Europol.
The analysis presented in the report examines topics such as the links between drugs and other...
Monitoring the Elimination of Viral Hepatitis as a Public Health Threat in Europe
This technical report focuses on an elimination barometer for viral hepatitis to help countries assess progress towards eliminating hepatitis C and B among people who inject drugs (PWID).
The barometer is being developed by the EMCDDA...
Prevention of Drug-Related Deaths
Opioids are a class of drugs that act on the nervous system to produce feelings of pleasure and pain relief. Opioids have a high potential for causing addiction in some people and can cause life-threatening health problems, including the...
EDPQS Toolkit 4: Adaptation and Dissemination
The European Drug Prevention Quality Standards have been 
established to provide a comprehensive set of criteria to help users learn how to recognise 'high quality' prevention activities, outline the necessary structurally and procedural...
EDPQS Toolkit 3: Training
The European Drug Prevention Quality Standards have been 
established to provide a comprehensive set of criteria to help users learn how to recognise 'high quality' prevention activities, outline the necessary structurally and procedural...
EDPQS Toolkit 2: Self-Assessment & Reflection
The European Drug Prevention Quality Standards have been 
established to provide a comprehensive set of criteria to help users learn how to recognise 'high quality' prevention activities, outline the necessary structurally and procedural...
EDPQS Toolkit 1: Funding & Decision-Making
The European Drug Prevention Quality Standards have been established to provide a 
comprehensive set of criteria to help users learn how to recognise 'high quality' prevention activities, outline the necessary structurally and procedural...
Hepatitis C New Models of Care for Drugs Services
Hepatitis C virus (HCV) infection has a high prevalence in people who inject drugs in Europe, although HCV infection is both preventable and curable.
European clinical guidelines recommend that all patients with chronic liver disease as a...
Infographics: European Drug Report 2019
EMCDDA has developed a range of downloadable infographics to illustrate findings from the European Drug Report 2019.
The aim of the report is to provide reliable and detailed evidence of the drug situation in Europes so that practice and...
European Drug Report (EDR) 2019: Trends and Developments
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has published the latest European Drug Report, which provides an analysis of the latest data on the drug trends across the European Union, Norway and Turkey.
The aim of...
Xchange Prevention Registry
Xchange is an online registry of evidence-based prevention programmes. In its first phase, the registry will make available manualised interventions that European evaluation studies show have beneficial outcomes relating to substance use...
Drug-Related Homicide in Europe: A First Review of the Data and Literature
EMCDDA, Lisbon, May 2018
Series type: EMCDDA Papers
Summary
Homicide is a violent act that generates high social costs. In particular, drug-related homicide (DRH) has the potential to act as an indicator of wider drug-related crime...
m-Health Applications for Responding to Drug Use and Associated Harms
Digital healthcare, also known as e-health, refers to tools and services that use information and communication technology to improve the prevention, diagnosis, treatment, monitoring and management of health.
Mobile health, or m-health...
Medical Use of Cannabis and Cannabinoids
The European Monitoring Centre for Drugs and Drug Addiction have released their first report on the medical use of cannabis.
The report is part of a new series called Cannabis, Controversies and Challenges, and is designed to explore the...
Models of Addiction
The science of addiction is complicated, and it continues to be a field where the debate over definitions, models, theories, and the most appropriate ways to respond continues.
EMCDDA's Insight Review provides a critical analysis of the...
Monitoring Drug Use in Recreational Settings across Europe
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) have released their latest technical report “Monitoring Drug Use in Recreational Settings across Europe: Conceptual Challenges and Methodological Innovations”.
The report...
Preventing Overdose Deaths in Europe
There were over 9000 fatal overdoses in Europe in 2016. Tackling this concerning issues remains a key priority for public health policy.
The European Monitoring Centre for Drugs and Drugs Addiction has published their latest perspective...
